Back
Immunome 10K Form
Buy
62
IMNM
Immunome
Last Price:
15.81
Seasonality Move:
6.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-03-25 | 10K | IMNM/Immunome Annual |
2020-11-16 | 10Q | IMNM/Immunome Quarterly |
Receive IMNM News And Ratings
See the #1 stock for the next 7 days that we like better than IMNM
IMNM Financial Statistics
Sales & Book Value
Annual Sales: | $14.02M |
---|---|
Cash Flow: | $-17.81M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.77 |
Price / Book: | 7.84 |
Profitability
EPS (TTM): | -3.31170 |
---|---|
Net Income (TTM): | $-106.81M |
Gross Margin: | -- |
Return on Equity: | -322.07% |
Return on Assets: | -128.97% |
Immunome Earnings Forecast
Key Immunome Financial Ratios
- The Research & Development expenses have been 164.71% of Revenue.
- The Interest Expense is -0.04% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Immunome Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | IMNM |
Website: | immunome.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.63 |
Quick Ratio: | 6.53 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |